‘Mor Yong’ says the Indian Covid make a little ineffective vaccine. There are no alternatives. There are 2 brands. Inject it quickly.
on June 19th Dr. Yong Phuworawan, director of the center, specializes in clinical virology. Pediatric Clinic, Chulalongkorn University Medical Faculty Facebook post Dr. Yong Phuworawan said that
Covid-19 vaccine in Thailand
It is now widely discussed and criticized for the vaccine used in Thailand. Everyone wants a vaccine that Thailand doesn’t have. We also want all kinds of vaccines to get as far as possible to the Thai people to control the spread of the disease. If there are a wide variety of vaccines that want to get a vaccine, they can go for the pediatric vaccine.
Right now, vaccines are not enough to meet the world’s needs. We want American vaccines, but we can’t find them. It’s not because we don’t want it. But no vaccine is provided. He will send it to us at the end of the year Moderna, Pfizer’s vaccines are probably after October (Q4), in which month we don’t know yet.
Now in Thailand the epidemic is so deadly that 30-40 people die every day, we can’t wait. All vaccines can reduce severity and reduce deaths. We have to give first as soon as possible. In the future, when there are enough vaccines, anyone who wants to upgrade with a vaccine can do so.
Delta virus strains (India) are believed to interfere with the effectiveness of the vaccine. However, it is small compared to the Beta strain (South Africa). Thailand’s outbreak is now still a British strain with up to 96 percent. AstraZeneca and Sinovac vaccines have been shown to reduce virulence and morbidity, as in the Phuket study.
In the future, when an outbreak of Delta or Native American tribes occurs and a higher level of immunity is required. We’re going to inject more with every vaccine we have, like the vaccine in the needle
Studies of heterogeneous vaccinations have clearly shown that the first dose of AstraZeneca plus Pfizer made the immune system as high as the two doses of Pfizer, but another notable difference was that the two doses were different, and there is a higher level of immunity in there the memory CD8 T cells.
Similarly, preliminary data from the research center showed that the first dose of the Sinovac vaccine, followed by the boosted immunity from AstraZeneca, was very high. To give more than Sinovac 2 needles and a high level than Pfizer brothers at all, so in the current state we should vaccinate as early as possible and cover the population as much as possible to prevent morbidity and mortality as soon as possible and if mutations that reduce the effectiveness of vaccines can be stimulated by other vaccines. or the same vaccine offers sufficient immunity to protect against this mutant virus. Until there is a new vaccine specifically for the mutated virus.
At the moment we have no choice: two vaccines will be available as soon as possible. In the future, when there are enough and different types of vaccines, who can stimulate with any vaccine, can. Do not worry about problems that have not arisen as it is said.
